194
Views
15
CrossRef citations to date
0
Altmetric
Full-Length Research Paper

Glycated-H2A histone is better bound by serum anti-DNA autoantibodies in SLE patients: Glycated-histones as likely trigger for SLE?

, &
Pages 19-28 | Received 10 Sep 2013, Accepted 28 Jun 2014, Published online: 28 Jul 2014

References

  • Bekeredjian-Ding, I. 2013. B cell encounters with apoptotic cells. Autoimmunity. 46: 307–311
  • Petri, M. 1996. Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort Perspective. Scand. J. Rheumatol. 25: 191–193
  • Monestier, M., and B. L. Kotzin. 1992. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. Rheum. Dis. Clin. North Am. 18: 415–436
  • Winfield, J. B., C. M. Brunner, and D. Koffler. 1978. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum. 21: 289–294
  • Sollner-Webb, B., R. D. Camerini-Otero, and G. Falsenfeld. 1976. Chromatin structure as probed by nucleosomes and proteases: evidence for the central role of histones H3 and H4. Cell. 9: 179–193
  • Doyle, H. A., D. W. Aswad, and M. J. Mamula. 2013. Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. Autoimmunity. 46: 6–13
  • Bout, Y. M., D. F. G. J. Wolthuis, M. F. M. Dirkx, et al. 2012. Apoptosis and NET formation in the pathogenesis of SLE. Autoimmunity. 45: 597–601
  • de Leeuw, K., R. Graff, R. De Vries, et al. 2007. Accumulation of advanced glycation end products in patients with systemic lupus erythematosus. Rheumatology. 46: 1551–1556
  • Takeuchi, M., and S. Yamagishi. 2009. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer’s disease. J. Alzheimer’s Dis. 16: 845–858
  • Frye, E. B., T. P. Degenhardt, S. R. Thorpe, and J. W. Baynes. 1998. Role of the Maillard reaction in aging of tissue proteins. Advance glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J. Biol. Chem. 273: 18714–18719
  • Schmidt, A. M., S. D. Yan, J. L. Wautier, and D. Stern. 1999. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 84: 489–497
  • Koh, G., D. H. Lee, and J. T. Woo. 2010. 2-Deoxy-d-ribose induces cellular damage by increasing oxidative stress and protein glycation in a pancreatic beta-cell line. Metabolism. 59: 325–332
  • Zglinicki, T. V. 2003. Aging at the molecular level. In: Biology of aging and its modulation. S. I. S Tattaan, ed. Kluwer academic publishers, The Netherlands. p. 563–589
  • Luger, K., and J. C. Hansen. 2005. Nucleosome and chromatin fibre dynamics. Curr. Opin. Struct. Biol. 15: 188–196
  • Woodcock, C. L., and S. Dimitrov. 2001. Higher-order structure of chromatin and chromosomes. Curr. Opin. Gent. Dev. 11: 130–135
  • Bojanovic, J. J., A. D. Jevtovic, V. S. Pantic, S. M. Dugandzic, and D. S. Jovanovic. 1970. Thymus nucleoproteins. Thymus histones in young and adult rats. Gerontologia. 16: 304–312
  • Bucala, R., and A. Cerami. 1992. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv. Pharmacol. 23: 1–34
  • Chen, Y.H., J. T. Yang, and H. M. Martinez. 1972. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry. 11: 4120–4131
  • Alam, K., A. Ali, and R. Ali. 1993. The effect of hydroxyl radical on the antigenicity of native DNA. FEBS Lett. 319: 66–70
  • Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227: 680–685
  • Goding, J. W. 1978. Use of staphylococcal protein A as an immunological reagent. J. Immunol. Methods. 20: 241–253
  • Ali, R., and K. Alam. 2002. Evaluation of antibodies against oxygen free radical-modified DNA by ELISA. Methods Mol. Biol. 186: 171–181
  • Alam, K., Moinuddin, and S. Jabeen. 2007. Immunogenicity of mitochondrial DNA modified by hydroxyl radical. Cell. Immunol. 247: 12–17
  • Khan, W. A., K. Alam, and Moinuddin. 2007. Catechol-estrogen modified DNA: a better antigen for cancer autoantibody. Arch. Biochem. Biophys. 465: 293–300
  • Sell, D. R., and V. M. Monnier. 1989. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentose in the aging process. J. Biol. Chem. 264: 21597–21602
  • Althaus, F. R., and C. Richter. 1987. ADP-ribosylation of proteins. Enzymology and biological significance. Mol. Biol. Biochem. Biophys. 37: 1–237
  • Kohda, S., Y. Kanayama, M. Okamura, et al. 1989. Clinical significance of antibodies to histones in systemic lupus erythematosus. J. Rheumatol. 16: 24–28
  • Ghedira, I., H. Landolsi, A. Mankai, et al. 2006. Anti-histones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot. Pathol. Biol. (Paris) 54: 148–154
  • Kato, T., M. Kurokawa, H. Sasakawa, et al. 2000. Analysis of accumulated T-cell clonotypes in patients with systemic lupus erythematosus. Arthritis Rheum. 43: 2712–2721
  • Greidinger, E. L. 2001. Apoptosis in lupus pathogenesis. Front. Biosci. 6: 1392–1402
  • Doyle, H. A., M.-L. Yang, M. T. Raycroft, et al. 2014. Autoantigens: Novel forms and presentation to the immune system. Autoimmunity. 47: 220–233
  • Perl, A. 2013. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nature Rev. Rheumat. 9: 674–686
  • Hasnain, S. E., and N. Ahmed. 2004. Leptospirosis. Lancet Infect. Dis. 4: 543–544
  • Bucciantini, M., E. Giannoni, F. Chiti, et al. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature (London). 416: 507–511
  • Jairajpuri, D. S., S. Fatima, and M. Saleemuddin. 2007. Immunoglobulin glycation with fructose: a comparative study. Clin. Chim. Acta. 378: 86–92
  • Liggins, J., and A. J. Furth. 1997. Role of protein-bound carbonyl groups in the formation of advanced glycation end products. Biochim. Biophy. Acta. 1361: 123–130
  • McCance, D. R., D. G. Dyer, J. A. Dunn, et al. 1993. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J. Clin. Invest. 91: 2470–2478
  • Nakanishi, I., A. Moutabarrik, T. Hara, et al. 1994. Identification and characterization of membrane cofactor protein (CD46) in the human kidneys. Eur. J. Immunol. 24: 1529–1535
  • Corbin, J., N. Methot, H. H. Wang, et al. 1998. Secondary structure analysis of individual transmembrane segments of the nicotinic acetylcholine receptor by circular dichroism and Fourier transform infrared spectroscopy. J. Biol. Chem. 273: 771–777
  • Arif, B., J. M. Ashraf, and Moinuddin, et al. 2012. Structural and immunological characterization of amadori-rich human serum albumin: Role in diabetes mellitus. Arch. Biochem. Biophys. 522: 17–25
  • Khan, M. A., K. Dixit, and Moinuddin, et al. 2014. Studies on peroxynitrite-modified H1 histone: implications in systemic lupus erythematosus. Biochimie. 97: 104–113
  • Fritzler, M. J., and E. M. Tan. 1978. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J. Clin. Invest. 62: 560–567

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.